Upregulation of ANXA2 was observed in many different cancer types, including hepatoma [9], pancreatic cancer [10], breast cancer [11], glioma [12], colorectal cancer [13], and GC [14]. Here, ANXA2 is linked to hepatocellular carcinoma.